{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T15:47:09Z","timestamp":1790264829015,"version":"4.1.0"},"reference-count":81,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2009,4]]},"DOI":"10.1016\/j.leukres.2008.08.017","type":"journal-article","created":{"date-parts":[[2008,10,2]],"date-time":"2008-10-02T08:51:23Z","timestamp":1222937483000},"page":"525-538","source":"Crossref","is-referenced-by-count":15,"title":["Allogeneic CD3\/CD28 cross-linked Th1 memory cells provide potent adjuvant effects for active immunotherapy of leukemia\/lymphoma"],"prefix":"10.1016","volume":"33","author":[{"given":"M.","family":"Har-Noy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Zeira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Fingerut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Or","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Slavin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2008.08.017_bib1","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/0008-8749(91)90307-W","article-title":"A study of cytokine production in acute graft-vs-host disease","volume":"134","author":"Smith","year":"1991","journal-title":"Cell Immunol"},{"key":"10.1016\/j.leukres.2008.08.017_bib2","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/sj.bmt.1703888","article-title":"Factors associated with survival in patients with progressive disease following autologous transplant for lymphoma","volume":"31","author":"Paltiel","year":"2003","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.leukres.2008.08.017_bib3","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1053\/j.seminoncol.2005.12.012","article-title":"Vaccine- and immune-based therapy in chronic lymphocytic leukemia","volume":"33","author":"Le Dieu","year":"2006","journal-title":"Semin Oncol"},{"key":"10.1016\/j.leukres.2008.08.017_bib4","first-page":"320","article-title":"Immunotherapy of hematological malignancies using dendritic cells","volume":"95","author":"Van de Velde","year":"2008","journal-title":"Bull Cancer"},{"key":"10.1016\/j.leukres.2008.08.017_bib5","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1007\/s00262-001-0232-8","article-title":"T-helper (Th)1\/Th2 imbalance in patients with previously untreated B-cell diffuse large cell lymphoma","volume":"50","author":"Mori","year":"2001","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.leukres.2008.08.017_bib6","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s002620050616","article-title":"Intracellular cytokine profile of T cells from children with acute lymphoblastic leukemia","volume":"49","author":"Zhang","year":"2000","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.leukres.2008.08.017_bib7","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/S0301-472X(99)00083-1","article-title":"Analysis of T-cell defects in the specific immune response against acute lymphoblastic leukemia cells","volume":"27","author":"Yotnda","year":"1999","journal-title":"Exp Hematol"},{"key":"10.1016\/j.leukres.2008.08.017_bib8","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1046\/j.1365-2141.1999.01219.x","article-title":"IL4 production and increased CD30 expression by a unique CD8+ T-cell subset in B-cell chronic lymphocytic leukaemia","volume":"104","author":"de Totero","year":"1999","journal-title":"Br J Haematol"},{"key":"10.1016\/j.leukres.2008.08.017_bib9","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1080\/10245330310001652437","article-title":"Th1\/Th2 cells in patients with multiple myeloma","volume":"9","author":"Murakami","year":"2004","journal-title":"Hematology"},{"key":"10.1016\/j.leukres.2008.08.017_bib10","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1056\/NEJM199210223271705","article-title":"Induction of immune responses in patients with B-cell lymphoma against the surface-immunoglobulin idiotype expressed by their tumors","volume":"327","author":"Kwak","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.leukres.2008.08.017_bib11","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1182\/blood.V89.9.3129","article-title":"Tumor-specific idiotype vaccines in the treatment of patients with B-cell lymphoma\u2014long-term results of a clinical trial","volume":"89","author":"Hsu","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2008.08.017_bib12","first-page":"1656","article-title":"Chronic lymphocytic leukemia-reactive T cells during disease progression and after autologous tumor cell vaccines","volume":"9","author":"Gitelson","year":"2003","journal-title":"Clin Cancer Res"},{"issue":"Suppl. S","key":"10.1016\/j.leukres.2008.08.017_bib13","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/PL00014051","article-title":"The critical role of Th1-dominant immunity in tumor immunology","volume":"46","author":"Nishimura","year":"2000","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.leukres.2008.08.017_bib14","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1046\/j.1523-1747.2000.00995.x","article-title":"Cutaneous T cell lymphoma reactive CD4+ cytotoxic T lymphocyte clones display a Th1 cytokine profile and use a fas-independent pathway for specific tumor cell lysis","volume":"115","author":"Echchakir","year":"2000","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.leukres.2008.08.017_bib15","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1002\/1097-0142(19940815)74:4<1275::AID-CNCR2820740416>3.0.CO;2-Q","article-title":"Tumor specific cytolysis by tumor infiltrating lymphocytes in breast cancer","volume":"74","author":"Baxevanis","year":"1994","journal-title":"Cancer"},{"key":"10.1016\/j.leukres.2008.08.017_bib16","first-page":"63","article-title":"Predominant expression of Th1-type cytokines in primary hepatic cancer and adjacent liver tissues","volume":"6","author":"Qiu","year":"2007","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"10.1016\/j.leukres.2008.08.017_bib17","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1097\/00002371-200411000-00007","article-title":"Immunization of HLA-A*0201 and\/or HLA-DPbeta1*04 patients with metastatic melanoma using epitopes from the NY-ESO-1 antigen","volume":"27","author":"Khong","year":"2004","journal-title":"J Immunother (1997)"},{"key":"10.1016\/j.leukres.2008.08.017_bib18","doi-asserted-by":"crossref","first-page":"6169","DOI":"10.4049\/jimmunol.175.9.6169","article-title":"Tumor progression can occur despite the induction of very high levels of self\/tumor antigen-specific CD8+ T cells in patients with melanoma","volume":"175","author":"Rosenberg","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.leukres.2008.08.017_bib19","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1517\/14712598.5.4.463","article-title":"Escape strategies and reasons for failure in the interaction between tumour cells and the immune system: how can we tilt the balance towards immune-mediated cancer control?","volume":"5","author":"Rivoltini","year":"2005","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.leukres.2008.08.017_bib20","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1006\/jaut.1999.0339","article-title":"The inhibitory effects of transforming growth factor-beta-1 (TGF-beta1) in autoimmune diseases","volume":"14","author":"Prud\u2019homme","year":"2000","journal-title":"J Autoimmun"},{"key":"10.1016\/j.leukres.2008.08.017_bib21","first-page":"197","article-title":"Naturally occurring self-reactive CD4(+)CD25(+) regulatory T cells: universal immune code","volume":"4","author":"Pakravan","year":"2007","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.leukres.2008.08.017_bib22","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1146\/annurev.iy.12.040194.005015","article-title":"Tolerance, danger, and the extended family","volume":"12","author":"Matzinger","year":"1994","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.leukres.2008.08.017_bib23","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1046\/j.1365-3083.2001.00973.x","article-title":"Introduction to the series Danger model of immunity","volume":"54","author":"Matzinger","year":"2001","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.leukres.2008.08.017_bib24","doi-asserted-by":"crossref","first-page":"3628","DOI":"10.1002\/1521-4141(200212)32:12<3628::AID-IMMU3628>3.0.CO;2-E","article-title":"CpG-ODN-induced inflammation is sufficient to cause T-cell-mediated autoaggression against hepatocytes","volume":"32","author":"Sacher","year":"2002","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.leukres.2008.08.017_bib25","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.1600-065X.1999.tb01321.x","article-title":"Autoaggression and tumor rejection: it takes more than self-specific T-cell activation","volume":"169","author":"Ganss","year":"1999","journal-title":"Immunol Rev"},{"key":"10.1016\/j.leukres.2008.08.017_bib26","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1084\/jem.20030966","article-title":"Physiological beta cell death triggers priming of self-reactive T cells by dendritic cells in a type-1 diabetes model","volume":"198","author":"Turley","year":"2003","journal-title":"J Exp Med"},{"key":"10.1016\/j.leukres.2008.08.017_bib27","doi-asserted-by":"crossref","first-page":"4168","DOI":"10.4049\/jimmunol.177.6.4168","article-title":"Killing of normal melanocytes, combined with heat shock protein 70 and CD40L expression, cures large established melanomas","volume":"177","author":"Sanchez-Perez","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.leukres.2008.08.017_bib28","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/j.0818-9641.2004.01286.x","article-title":"Aluminium compounds for use in vaccines","volume":"82","author":"Lindblad","year":"2004","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.leukres.2008.08.017_bib29","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1586\/14760584.2.2.197","article-title":"MF59-adjuvanted vaccines: increased immunogenicity with an optimal safety profile","volume":"2","author":"Podda","year":"2003","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.leukres.2008.08.017_bib30","doi-asserted-by":"crossref","first-page":"3658","DOI":"10.1016\/j.vaccine.2004.03.032","article-title":"Aluminium adjuvants\u2014in retrospect and prospect","volume":"22","author":"Lindblad","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.leukres.2008.08.017_bib31","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/j.mehy.2007.10.008","article-title":"The anti-tumor effect of allogeneic bone marrow\/stem cell transplant without graft vs. host disease toxicity and without a matched donor requirement?","volume":"70","author":"Har-Noy","year":"2008","journal-title":"Med Hypotheses"},{"issue":"12","key":"10.1016\/j.leukres.2008.08.017_bib32","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/j.leukres.2008.05.007","article-title":"Completely mismatched allogeneic CD3\/CD28 cross-linked Th1 memory cells elicit anti-leukemia effects in unconditioned hosts without GVHD toxicity","volume":"32","author":"Har-Noy","year":"2008","journal-title":"Leuk Res Jun"},{"key":"10.1016\/j.leukres.2008.08.017_bib33","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/ni1102-991","article-title":"Cancer immunoediting: from immunosurveillance to tumor escape","volume":"3","author":"Dunn","year":"2002","journal-title":"Nat Immunol"},{"key":"10.1016\/j.leukres.2008.08.017_bib34","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1084\/jem.179.4.1127","article-title":"Turnover of naive- and memory-phenotype T cells","volume":"179","author":"Tough","year":"1994","journal-title":"J Exp Med"},{"key":"10.1016\/j.leukres.2008.08.017_bib35","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1600-065X.1991.tb00605.x","article-title":"Subsets of CD4+ T cells and their roles in the induction and prevention of autoimmunity","volume":"123","author":"Fowell","year":"1991","journal-title":"Immunol Rev"},{"key":"10.1016\/j.leukres.2008.08.017_bib36","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1084\/jem.179.2.589","article-title":"Regulatory interactions between CD45RBhigh and CD45RBlow CD4+ T cells are important for the balance between protective and pathogenic cell-mediated immunity","volume":"179","author":"Powrie","year":"1994","journal-title":"J Exp Med"},{"key":"10.1016\/j.leukres.2008.08.017_bib37","doi-asserted-by":"crossref","first-page":"5353","DOI":"10.4049\/jimmunol.163.10.5353","article-title":"CD4+ CD45RB low-density cells from untreated mice prevent acute allograft rejection","volume":"163","author":"Davies","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.leukres.2008.08.017_bib38","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1038\/15200","article-title":"Natural adjuvants: endogenous activators of dendritic cells","volume":"5","author":"Gallucci","year":"1999","journal-title":"Nat Med"},{"key":"10.1016\/j.leukres.2008.08.017_bib39","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1084\/jem.191.3.423","article-title":"Consequences of cell death: exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells","volume":"191","author":"Sauter","year":"2000","journal-title":"J Exp Med"},{"key":"10.1016\/j.leukres.2008.08.017_bib40","first-page":"562","article-title":"Expression of human soluble CD40 ligand in Pichia pastoris and its effects on dendritic cells and malignant B cells","volume":"32","author":"Shi","year":"2000","journal-title":"Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai)"},{"key":"10.1016\/j.leukres.2008.08.017_bib41","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1046\/j.0022-202x.2001.01313.x","article-title":"Inflammatory changes after cryosurgery-induced necrosis in human melanoma xenografted in nude mice","volume":"116","author":"Gazzaniga","year":"2001","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.leukres.2008.08.017_bib42","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1088\/0031-9155\/26\/4\/001","article-title":"Biophysical and engineering aspects of cryosurgery","volume":"26","author":"Orpwood","year":"1981","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.leukres.2008.08.017_bib43","doi-asserted-by":"crossref","first-page":"C125","DOI":"10.1152\/ajpcell.1984.247.3.C125","article-title":"Freezing of living cells: mechanisms and implications","volume":"247","author":"Mazur","year":"1984","journal-title":"Am J Physiol"},{"key":"10.1016\/j.leukres.2008.08.017_bib44","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1159\/000128303","article-title":"Cryoimmunotherapy: a conference report","volume":"14","author":"Ablin","year":"1982","journal-title":"Eur Surg Res"},{"key":"10.1016\/j.leukres.2008.08.017_bib45","first-page":"378","article-title":"Specific inhibition of antibody production. II. Paralysis induced in adult mice by small quantities of protein antigen","volume":"5","author":"Dresser","year":"1962","journal-title":"Immunology"},{"key":"10.1016\/j.leukres.2008.08.017_bib46","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1182\/blood.V90.4.1611","article-title":"T helper 2-dominant antilymphoma immune response is associated with fatal outcome","volume":"90","author":"Lee","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2008.08.017_bib47","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0145-2126(01)00194-1","article-title":"T type 1\/type 2 subsets balance in B-cell chronic lymphocytic leukemia\u2014the three-color flow cytometry analysis","volume":"26","author":"Podhorecka","year":"2002","journal-title":"Leuk Res"},{"key":"10.1016\/j.leukres.2008.08.017_bib48","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1479-5876-3-8","article-title":"Revisiting immunosurveillance and immunostimulation: implications for cancer immunotherapy","volume":"3","author":"Ichim","year":"2005","journal-title":"J Transl Med"},{"key":"10.1016\/j.leukres.2008.08.017_bib49","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1007\/s001099900066","article-title":"Apoptosis or necrosis for tumor immunotherapy: what's in a name?","volume":"77","author":"Melcher","year":"1999","journal-title":"J Mol Med"},{"key":"10.1016\/j.leukres.2008.08.017_bib50","doi-asserted-by":"crossref","first-page":"577","DOI":"10.3109\/07357909709047600","article-title":"Development of vaccine strategies for the treatment of B-cell malignancies","volume":"15","author":"Kobrin","year":"1997","journal-title":"Cancer Invest"},{"key":"10.1016\/j.leukres.2008.08.017_bib51","doi-asserted-by":"crossref","first-page":"365","DOI":"10.4049\/jimmunol.145.1.365","article-title":"Vaccination with membrane-associated idiotype provides greater and more prolonged protection of animals from tumor challenge than the soluble form of idiotype","volume":"145","author":"Ghosh","year":"1990","journal-title":"J Immunol"},{"key":"10.1016\/j.leukres.2008.08.017_bib52","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.4049\/jimmunol.141.6.2168","article-title":"Idiotypic vaccination as a treatment for a B cell lymphoma","volume":"141","author":"George","year":"1988","journal-title":"J Immunol"},{"key":"10.1016\/j.leukres.2008.08.017_bib53","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/S0952-7915(97)80153-7","article-title":"Origin, maturation and antigen presenting function of dendritic cells","volume":"9","author":"Cella","year":"1997","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.leukres.2008.08.017_bib54","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1159\/000319477","article-title":"Role of interleukin-12 in human Th1 response","volume":"63","author":"Trinchieri","year":"1996","journal-title":"Chem Immunol"},{"key":"10.1016\/j.leukres.2008.08.017_bib55","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1093\/intimm\/10.8.1017","article-title":"Induction of Th2 cell differentiation in the primary immune response: dendritic cells isolated from adherent cell culture treated with IL-10 prime naive CD4+ T cells to secrete IL-4","volume":"10","author":"Liu","year":"1998","journal-title":"Int Immunol"},{"key":"10.1016\/j.leukres.2008.08.017_bib56","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1002\/eji.1830270526","article-title":"Effect of interleukin-10 on dendritic cell maturation and function","volume":"27","author":"De Smedt","year":"1997","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.leukres.2008.08.017_bib57","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1067\/mai.2002.120556","article-title":"Dendritic cells contribute to the development of atopy by an insufficiency in IL-12 production","volume":"109","author":"Reider","year":"2002","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.leukres.2008.08.017_bib58","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1084\/jem.188.5.887","article-title":"Antiinflammatory effects of CD95 ligand (FasL)-induced apoptosis","volume":"188","author":"Gao","year":"1998","journal-title":"J Exp Med"},{"key":"10.1016\/j.leukres.2008.08.017_bib59","doi-asserted-by":"crossref","first-page":"5383","DOI":"10.4049\/jimmunol.163.10.5383","article-title":"Proteoglycan (aggrecan)-induced arthritis in BALB\/c mice is a Th1-type disease regulated by Th2 cytokines","volume":"163","author":"Finnegan","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.leukres.2008.08.017_bib60","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/79734","article-title":"Dendritic cell regulation of TH1-TH2 development","volume":"1","author":"Moser","year":"2000","journal-title":"Nat Immunol"},{"key":"10.1016\/j.leukres.2008.08.017_bib61","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.4049\/jimmunol.160.4.1701","article-title":"CD40 ligand\/CD40 stimulation regulates the production of IFN-gamma from human peripheral blood mononuclear cells in an IL-12- and\/or CD28-dependent manner","volume":"160","author":"McDyer","year":"1998","journal-title":"J Immunol"},{"key":"10.1016\/j.leukres.2008.08.017_bib62","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1006\/bbrc.1994.1122","article-title":"IFN-gamma induces IL-12 mRNA expression by a murine macrophage cell line, J774","volume":"198","author":"Yoshida","year":"1994","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.leukres.2008.08.017_bib63","doi-asserted-by":"crossref","first-page":"4485","DOI":"10.1182\/blood-2002-10-3108","article-title":"Tumor-derived, chaperone-rich cell lysate activates dendritic cells and elicits potent antitumor immunity","volume":"101","author":"Zeng","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2008.08.017_bib64","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S1074-7613(00)80570-1","article-title":"Heat shock proteins come of age: primitive functions acquire new roles in an adaptive world","volume":"8","author":"Srivastava","year":"1998","journal-title":"Immunity"},{"key":"10.1016\/j.leukres.2008.08.017_bib65","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/S1357-4310(98)01345-8","article-title":"Heat shock protein\u2014peptide complexes as immunotherapy for human cancer","volume":"4","author":"Przepiorka","year":"1998","journal-title":"Mol Med Today"},{"key":"10.1016\/j.leukres.2008.08.017_bib66","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1007\/s00262-002-0359-2","article-title":"Tumor-derived chaperone-rich cell lysates are effective therapeutic vaccines against a variety of cancers","volume":"52","author":"Graner","year":"2003","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.leukres.2008.08.017_bib67","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1182\/blood-2004-05-1915","article-title":"Induction of BCR-ABL-specific immunity following vaccination with chaperone-rich cell lysates derived from BCR-ABL+ tumor cells","volume":"105","author":"Zeng","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2008.08.017_bib68","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1096\/fj.06-7843com","article-title":"Chaperone-rich cell lysate embedded with BCR-ABL peptide demonstrates enhanced anti-tumor activity against a murine BCR-ABL positive leukaemia","volume":"21","author":"Kislin","year":"2007","journal-title":"FASEB J"},{"key":"10.1016\/j.leukres.2008.08.017_bib69","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1189\/jlb.0907635","article-title":"Chaperone-rich tumor cell lysate-mediated activation of antigen-presenting cells resists regulatory T cell suppression","volume":"83","author":"Larmonier","year":"2008","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.leukres.2008.08.017_bib70","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/77835","article-title":"CD91: a receptor for heat shock protein gp96","volume":"1","author":"Binder","year":"2000","journal-title":"Nat Immunol"},{"key":"10.1016\/j.leukres.2008.08.017_bib71","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1084\/jem.188.9.1705","article-title":"Protective heterologous antiviral immunity and enhanced immunopathogenesis mediated by memory T cell populations","volume":"188","author":"Selin","year":"1998","journal-title":"J Exp Med"},{"key":"10.1016\/j.leukres.2008.08.017_bib72","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/S0002-9440(10)63493-1","article-title":"Specific history of heterologous virus infections determines anti-viral immunity and immunopathology in the lung","volume":"163","author":"Chen","year":"2003","journal-title":"Am J Pathol"},{"key":"10.1016\/j.leukres.2008.08.017_bib73","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0047-6374(96)01708-3","article-title":"Dysregulation between TH1 and TH2 T cell subpopulations in the elderly","volume":"87","author":"Cakman","year":"1996","journal-title":"Mech Ageing Dev"},{"key":"10.1016\/j.leukres.2008.08.017_bib74","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1046\/j.1365-2249.2002.01736.x","article-title":"Is ageing associated with a shift in the balance between Type 1 and Type 2 cytokines in humans?","volume":"127","author":"Sandmand","year":"2002","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.leukres.2008.08.017_bib75","doi-asserted-by":"crossref","first-page":"d1056","DOI":"10.2741\/A831","article-title":"T cells and aging, January 2002 update","volume":"7","author":"Pawelec","year":"2002","journal-title":"Front Biosci"},{"key":"10.1016\/j.leukres.2008.08.017_bib76","doi-asserted-by":"crossref","first-page":"4955","DOI":"10.1158\/1078-0432.CCR-04-2422","article-title":"Combined dendritic cell cryotherapy of tumor induces systemic antimetastatic immunity","volume":"11","author":"Machlenkin","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.leukres.2008.08.017_bib77","doi-asserted-by":"crossref","first-page":"7465","DOI":"10.1158\/1078-0432.CCR-06-1840","article-title":"Enhancement of immunologic tumor regression by intratumoral administration of dendritic cells in combination with cryoablative tumor pretreatment and Bacillus Calmette-Guerin cell wall skeleton stimulation","volume":"12","author":"Udagawa","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.leukres.2008.08.017_bib78","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/304030a0","article-title":"A cell-surface molecule involved in organ-specific homing of lymphocytes","volume":"304","author":"Gallatin","year":"1983","journal-title":"Nature"},{"key":"10.1016\/j.leukres.2008.08.017_bib79","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1126\/science.278.5338.672","article-title":"Requirement for CD44 in activated T cell extravasation into an inflammatory site","volume":"278","author":"DeGrendele","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.leukres.2008.08.017_bib80","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1182\/blood-2002-06-1736","article-title":"Glycosylation-dependent inhibition of cutaneous lymphocyte-associated antigen expression: implications in modulating lymphocyte migration to skin","volume":"101","author":"Dimitroff","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2008.08.017_bib81","doi-asserted-by":"crossref","first-page":"6025","DOI":"10.4049\/jimmunol.173.10.6025","article-title":"The immunization site of cytokine-secreting tumor cell vaccines influences the trafficking of tumor-specific T lymphocytes and antitumor efficacy against regional tumors","volume":"173","author":"Chang","year":"2004","journal-title":"J Immunol"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212608003810?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212608003810?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T06:12:18Z","timestamp":1684563138000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212608003810"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4]]},"references-count":81,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,4]]}},"alternative-id":["S0145212608003810"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2008.08.017","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2009,4]]}}}